HITHITTechnology · Software - Application

HIT Stock Forecast: Health In Tech, Inc. Price Predictions for 2026-2027

Last close, 30 Oct 2026
$0.58
−5.67% on the day

The 2 Wall Street analysts covering Health In Tech, Inc. hold a median 12-month price target of $4 — +592.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 12 of 100 as at 31 Oct 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$37.7M
Ticker Nerd rank
12/ 100
Median analyst target
$4.00
Analysts covering
2
Revenue$8.1M−13.5% y/y
Operating income−$3.4M
Net income−$2.5M
Free cash flow−$3.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+2.7%
1M
−29.7%
YTD
−63.7%
1Y
−77.9%
From 52W high
−80.4%
From 52W low
+7.7%
$0.54
$2.94
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HIT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Health In Tech, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 31 Oct 2026
12/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
82
Issuance
46
Quality
40
Revisions
29
Growth
27
Value
26
Volatility
22
Accruals
15
Momentum
5

Size (82): Smaller than most of the companies we track.

Momentum (5): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

HIT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HIT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$1.00$2.00$3.00$4.00Jan 26Apr 26Jul 26Oct 26HITHigh $4.10Median $4.00Low $1.25

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
2 Buy0 Hold0 Sell
Low $1.25Median $4.00High $4.10

The green dot is the last close — the median target sits +592.9% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
14 Aug 2026Maxim GroupMaintainsBuy$4.00 → $3.00
20 Apr 2026Craig-HallumInitiatesBuy$4.00
20 Apr 2026Craig-HallumInitiatesBuy—
26 June 2025Maxim GroupInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

HIT appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.

Free. Unsubscribe any time.

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and serversIn full

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

HIT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 30 Oct 2026, Health In Tech, Inc. returned −77.9% against +12.4% for the S&P 500, dividends included.

HIT vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120Jan 26Apr 26Jul 26Oct 26HITS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

HIT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

Health In Tech, Inc. (HIT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
76.0×

Cheaper than 9% of US stocks

Price / sales
1.1×

Cheaper than 64% of US stocks

Price / book
1.9×

Cheaper than 43% of US stocks

EV / EBITDA
12.2×

Cheaper than 28% of US stocks

Growth & margins
Revenue growth (YoY)
−13.5%

Higher than 14% of US stocks

Earnings growth (YoY)
−13.5%

Higher than 24% of US stocks

Gross margin
48.7%

Higher than 60% of US stocks

Operating margin
−42.7%

Higher than 18% of US stocks

Net margin
−12.0%

Higher than 19% of US stocks

Returns & dividend
Return on equity
−21.9%

Higher than 31% of US stocks

Return on assets
−12.7%

Higher than 24% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Health In Tech, Inc. (HIT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Health In Tech, Inc. has a market value of $37.7M and an enterprise value of $31.5M.

  • Revenue in the twelve months to 30 June 2026: $32.8M. The latest quarter shrank 13.5% year on year.

  • Net income over the same four quarters: −$3.9M, a −12.0% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.07.

  • Free cash flow in the twelve months to 30 June 2026: −$7.6M.

  • Shares outstanding: 65.6M.

  • Trailing P/E: 76.0×; forward P/E: −28.9× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Health In Tech, Inc. employs 87 people — $377K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 1 Nov 2026

Data provided by Twelve Data

Peers

HIT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSoftware - Application
CompanyMarket capTKN rank
HITHealth In Tech, Inc.$37.7M12
PHUNPhunware, Inc.$37.8M15
DGNXDiginex Ltd. (Hong Kong)$40.7M10
CRGOFreightos Ltd.$34.6M47
WQEYWISeQey Corp.$33.9M16
ATHRAether Holdings, Inc.$32.2M23
FRMMForum Markets, Inc.$45.6M18

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Health In Tech, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HIT news & analysis

Health In Tech Appoints Sanjay Shrestha as Chief Executive Officer to Lead Next Phase of Growth and Strategic Expansion

PRNewsWire · 20 Oct 2026positive

Health In Tech appointed Sanjay Shrestha, formerly President of Plug Power, as CEO. Founder Tim Johnson will become Executive Chairman and continue leading long-term strategy, technology innovation and product development.

Why it matters — The leadership change gives HIT a CEO mandate focused on scaling existing businesses, commercialization, acquisitions and strategic partnerships.

Health In Tech to Host Annual Meeting of Stockholders

PRNewsWire · 16 Oct 2026neutral

Health In Tech said it will hold its 2026 Annual Meeting of Stockholders on Tuesday, November 10, 2026, at 10:00 a.m. ET. The meeting will be conducted via live virtual webcast.

Why it matters — HIT watchers may note the date and format for the company’s annual stockholder meeting.

Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement

PRNewsWire · 8 Oct 2026positive

Health In Tech launched HitRix, a broker-first environment for self-funded stop-loss placement. It combines submission intake, market routing, quote comparison and case tracking in one coordinated process.

Why it matters — HIT watchers may note the launch as a new marketplace offering focused on streamlining the stop-loss placement process for brokers.

Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference

PRNewsWire · 2 Oct 2026neutral

Health In Tech, Inc. (Nasdaq: HIT) announced that representatives from its management and investor relations teams will attend the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026, at the Sheraton New York Times Square Hotel in New York City.

Why it matters — The conference participation provides HIT with an opportunity to present its AI-enabled InsurTech platform to investors and industry participants.

FAQ

Frequently asked questions about HIT stock

What is the HIT stock price forecast for 2026-2027?

The 2 Wall Street analysts covering Health In Tech, Inc. have a median 12-month price target of $4, with estimates ranging from $1.25 to $4.1. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HIT stock a buy right now?

Of the 2 analysts covering Health In Tech, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Health In Tech, Inc. 12 out of 100 across roughly 4,600 US stocks as at 31 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HIT?

As at 31 Oct 2026, Health In Tech, Inc. ranks 12 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (82 of 100).

Will HIT stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +592.9% from the last close, and Ticker Nerd's factor model ranks Health In Tech, Inc. 12 out of 100 as at 31 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HIT stock forecast for 2030?

No analyst covering Health In Tech, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HIT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1.25 to $4.1 over the next 12 months.

How has HIT stock performed over the past year?

Health In Tech, Inc. returned -77.9% over the 12 months to 30 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Health In Tech, Inc. do?

Health In Tech Inc. Class A Common Stock represents the public equity of Health In Tech Inc., an insurance technology platform company focused on the healthcare and insurance ecosystem.

What is the latest news on HIT?

The most recent item we track (PRNewsWire, 29 Oct 2026): "Health In Tech to Announce Third Quarter 2026 Financial Results on November 12, 2026". Health In Tech announced it will report financial results for the third quarter ended September 30, 2026, after market close on November 12, 2026.

Company

About Health In Tech, Inc.

Health In Tech Inc. Class A Common Stock represents the public equity of Health In Tech Inc., an insurance technology platform company focused on the healthcare and insurance ecosystem. Health In Tech provides a marketplace designed to simplify underwriting, sales, and service workflows through vertical integration, process automation, and AI-enabled tools. Its current offerings include group insurance captives, community health plans, association health programs, self-funded benefits administration, stop-loss underwriting support, web-based quoting software, and services that help manage medical records, claims, and provider network pricing. The company serves small and medium-sized employers, licensed brokers, insurance companies, and third-party administrators, positioning itself as a technology layer that streamlines core insurance operations. Health In Tech Inc. is headquartered in Stuart, Florida.

CEO Mr. Tim Johnson · 87 employees · United States · https://healthintech.com